2026 NPPES data Cardiovascular Disease Physician NPI 1871675785 M.D.
Verify on CMS →

John Pantazopoulos, M.D.

Cardiovascular Disease Physician in Fair Lawn, New Jersey.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 24,810 in Cardiovascular Disease Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
2K
Medicare Part D claims · 183 beneficiaries · Cardiovascular Disease Physician avg: 3K
Generic prescribing
86%
generic claims · 14% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$129.36
1 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

John Pantazopoulos, M.D. filed 2,321 Medicare Part D claims in 2023 as a Cardiovascular Disease Physician in Fair Lawn, New Jersey, prescribing 86% generic.

2K
Part D claims, 2023
86%
generic prescribing
$129.36
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

John Pantazopoulos, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023, across all CMS prescribers nationally

2,321 Top 14% higher than 86% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). Below this entry. 1,000–1,200: 31,827 prescribers (2%). Below this entry. 1,200–1,400: 26,224 prescribers (2%). Below this entry. 1,400–1,600: 21,710 prescribers (2%). Below this entry. 1,600–1,800: 19,072 prescribers (1%). Below this entry. 1,800–2,000: 16,451 prescribers (1%). Below this entry. 2K+: 213,991 prescribers (16%). This entry sits in this band. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic, not verified)

John Pantazopoulos, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about John Pantazopoulos, M.D.?

Quality data not reported

NPI registry status

Active

Issued 10/19/2006

NPI 1871675785

Primary specialty

Cardiovascular Disease Physician

Mid-sized

24,810 US NPIs in this specialty

Medicare Part D claims

2,321 23% vs specialty avg

2023 prescription claims

Specialty avg: 3,033

Specialty distribution in New Jersey

How Cardiovascular Disease Physician compares to other specialties among New Jersey providers

New Jersey providers
Mental Health Counselor6.2%Physical Therapist5.9%Clinical Social Worker5.5%Student in an Organized Heal…5.4%Pharmacist5%Internal Medicine Physician3.1%Cardiovascular Disease Physi…0.6%
Largest specialties in New Jersey (% of in-state providers)

Board certification

Not published by CMS

CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Cardiovascular Disease Physician. Verify directly:

How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

John Pantazopoulos, M.D. appears in the CMS NPPES registry as a Cardiovascular Disease Physician provider holding M.D. credentials at 23-00 ROUTE 208, Fair Lawn, NJ, 07410, with a listed phone of (201) 262-9200. NPI 1871675785 was issued on 10/19/2006.

Medicare Part D records for calendar year 2023 show 2,321 prescription claims written by this provider, covering 183 Medicare beneficiaries and totaling roughly $302K in drug spend, split 14% brand-name and 86% generic by claim count.

Cardiovascular Disease Physician is a mid-sized specialty nationwide, with 24,810 enrolled providers across 54 states and an average of 3,033 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.

Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

23-00 ROUTE 208
Fair Lawn, NJ 07410

Provider Details

NPI 1871675785
Specialty Cardiovascular Disease Physician
Credentials M.D.
Gender Male
NPI Issued 10/19/2006

Industry payments received (2024) - CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for John Pantazopoulos, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$129

Largest payer

Abbott Laboratories

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Typical

John Pantazopoulos, M.D. - brand share 14.0%
Cardiovascular Disease Physician average

14% brand-name claims vs 86% generic, on 2,321 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

2,321
Total Claims
$302K
Total Drug Cost
183
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
6,194
Total Day Supply
185,452
Brand vs Generic
14% brand / 86% generic
Brand Drug Cost
$230K
Generic Drug Cost
$72K

Patient Demographics

Average Patient Age
78.9 years
Avg HCC Risk Score
1.32
Gender Split
49% female / 51% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What John Pantazopoulos, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Nifedipine Er
Nifedipine
412
Rosuvastatin Calcium
296
Metoprolol Succinate
261
Candesartan Cilexetil
135
Pravastatin Sodium
98
Eliquis
Apixaban
91
Levothyroxine Sodium
88
Spironolactone
83
Jardiance
Empagliflozin
62
Metformin Hcl
57

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Cardiovascular Disease Physician Overview

How John Pantazopoulos, M.D. fits within the Cardiovascular Disease Physician landscape nationally.

24,810
Cardiovascular Disease Physician Providers in US
54
States with Cardiovascular Disease Physician
3,033
Avg Claims per Provider

John Pantazopoulos, M.D.'s 2,321 claims are below the specialty average of 3,033.

Nearby Cardiovascular Disease Physician Providers in New Jersey

Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as Pantazopoulos.

Compare Cardiovascular Disease Physician nationally: see state-by-state distribution →

Before you book an appointment

Use this federal record as your verification checklist, not as a recommendation.

  • Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
  • Check the active license and any disciplinary history with the New Jersey medical board, federal registration is not a license check. Credential verification guide
  • Weigh a second option: compare this provider with a nearby Cardiovascular Disease Physician peer on Medicare volume and prescribing patterns. Compare providers

Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.

Frequently Asked Questions

What is John Pantazopoulos, M.D.'s specialty?
John Pantazopoulos, M.D. specializes in Cardiovascular Disease Physician and practices in Fair Lawn, New Jersey. Credentials: M.D..
How much does John Pantazopoulos, M.D. prescribe under Medicare Part D?
In 2023, John Pantazopoulos, M.D. wrote 2,321 Medicare Part D claims totaling $302K in drug costs for 183 beneficiaries.
Where is John Pantazopoulos, M.D. located?
John Pantazopoulos, M.D. is located at 23-00 ROUTE 208, Fair Lawn, NJ, 07410. Phone: (201) 262-9200.
What is John Pantazopoulos, M.D.'s NPI number?
John Pantazopoulos, M.D.'s National Provider Identifier (NPI) is 1871675785, issued on 10/19/2006.
Does John Pantazopoulos, M.D. prescribe more brand-name or generic drugs?
John Pantazopoulos, M.D.'s prescribing is 14% brand-name and 86% generic drugs by claim count, with $230K in brand drug costs.
How many Cardiovascular Disease Physician providers are there in the US?
There are 24,810 Cardiovascular Disease Physician providers across 54 states in the US. The average Cardiovascular Disease Physician provider writes 3,033 Medicare Part D claims per year.
What drugs does John Pantazopoulos, M.D. prescribe most often?
Based on 2023 Medicare Part D data, John Pantazopoulos, M.D.'s most frequently prescribed drugs include Nifedipine Er, Rosuvastatin Calcium, Metoprolol Succinate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does John Pantazopoulos, M.D. accept Medicare?
John Pantazopoulos, M.D. appears in CMS Medicare data with 2,321 Part D claims and 183 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify John Pantazopoulos, M.D.'s credentials?
John Pantazopoulos, M.D.'s NPI is 1871675785 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Compiled from official public sources by the editorial process.

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.